Jana Koch

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Cancer Stem Cells

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Adrian Salega, Marina Münch, Philipp Renner, Klaus-Peter Thon, Wolfgang Steurer, Dina Mönch, Jana Koch, Annika Maaß, Hans Jürgen Schlitt, Marc-Hendrik Dahlke, Tobias Leibold
Late Local Recurrence after Neoadjuvant Therapy and Radical Resection for Locally Advanced Rectal Cancer. Cancers 16 (2) (2024)
Adrian Salega, Marina Münch, Philipp Renner, Klaus-Peter Thon, Wolfgang Steurer, Dina Mönch, Jana Koch, Annika Maaß, Hans Jürgen Schlitt, Marc-Hendrik Dahlke, Tobias Leibold
Late Local Recurrence after Neoadjuvant Therapy and Radical Resection for Locally Advanced Rectal Cancer. Cancers 16 (2) (2024)
Jana Koch, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Irina Smirnow, Andrea Schenk, Mary E Carter, Linus D Kloker, Tobias Leibold, Philipp Renner, Marc-H Dahlke, Ulrich M Lauer
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model. Viruses 15 (2) (2023)
Jana Koch, Julia Beil, Susanne Berchtold, Dina Mönch, Annika Maaß, Irina Smirnow, Andrea Schenk, Mary E Carter, Linus D Kloker, Tobias Leibold, Philipp Renner, Marc-H Dahlke, Ulrich M Lauer
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model. Viruses 15 (2) (2023)
Jana Koch, Sebastian Johannes Schober, Sruthi V Hindupur, Caroline Schöning, Florian Gerhard Klein, Klaus Mantwill, Maximilian Ehrenfeld, Ulrike Schillinger, Timmy Hohnecker, Pan Qi, Katja Steiger, Michaela Aichler, Jürgen E Gschwend, Roman Nawroth, Per Sonne Holm
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus. Nature communications 13 (1) (2022)
Jana Koch, Dina Mönch, Annika Maaß, Alina Mangold, Miodrag Gužvić, Thomas Mürdter, Tobias Leibold, Marc-H Dahlke, Philipp Renner
Pharmacologic Targeting of MMP2/9 Decreases Peritoneal Metastasis Formation of Colorectal Cancer in a Human Ex Vivo Peritoneum Culture Model. Cancers 14 (15) (2022)
Jana Koch, Dina Mönch, Annika Maaß, Christian Gromoll, Thomas Hehr, Tobias Leibold, Hans J Schlitt, Marc-H Dahlke, Philipp Renner
Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines. PloS one 16 (1) (2021)